Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 4 recruiting now early-phase tilt small index

Claudication: early-phase trial registry

4 of 5 indexed Claudication trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #3,391 of 28,707 conditions by registered trial count.

5 US clinical trials · 4 currently recruiting · #3,391 of 28,707 conditions by registered trial count

Claudication: 5 US clinical trials tracked, 4 recruiting.

Claudication is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is University of Oklahoma, running 3 of these trials.

Enrollment posture brief

Registry condition claudication

OPEN 4 | RECR 80% | LATE 0 | EARLY 1 | RANK #3391 | SPON 3

Nearest open-share peer: Acute Leukemia of Ambiguous Lineage (80% recruiting · 10 trials)

Ablation80%ACL Reconstruction80%Claudication (this)80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Claudication

Claudication lists 4 open slots (80% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Claudication on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Claudication is recruiting above its size-band peers.

    4 of 5 indexed trials (80%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Claudication research.

    University of Oklahoma accounts for 3 of 5 trials (60%). 3 distinct sponsors appear on at least one study for this condition label.

  3. Most Claudication trials plan to enrol fewer than 100 people.

    Median target enrolment is 50 among the 5 trials that report a genuine target (sentinel values excluded). 3 of those (60%) plan for fewer than 100 participants.

  4. Claudication research is mostly interventional.

    4 interventional and 1 observational studies make up this index (80% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 21

Phase Distribution

PhaseTrial count
Phase 2 1

Top Sponsors

Named interventions

Most-linked intervention names on Claudication records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Home-Based Exercise Behavioral
1 trials
DASH Diet plus Home-Based Exercise Behavioral
1 trials
Shockwave Intravascular Lithotripsy (IVL) Device
1 trials
Walking Exercise Behavioral
1 trials
Control Behavioral
1 trials
Fisetin Drug
1 trials
Exercise Behavioral
1 trials
Placebo Drug
1 trials

US sites by state

Facility locations filed on Claudication trials. A trial with sites in several states counts in each.

Oklahoma 2 trials
Rhode Island 1 trials
Pennsylvania 1 trials
Illinois 1 trials
Connecticut 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Claudication page

5 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Claudication condition card totals 5 registered trials; most-linked intervention Home-Based Exercise; top US site state Oklahoma. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.